Disclaimer: This content is for educational and informational purposes only and does not constitute financial, investment, or trading advice.

LLY (Eli Lilly and Company)

Ticker: LLY
Bias: Bullish trend continuation
Strategy: Trend-following + mean reversion

LLY is consolidating near trend support after a strong advance, with multi-timeframe price action signaling a bullish continuation setup.

Thesis Summary

Eli Lilly and Company (LLY) presents a bullish technical setup across multiple timeframes, with recent price action favoring consolidation over trend reversal. On the 4H chart, a classic bullish pin bar formed after a pullback and was confirmed by a bullish candle closing higher, signaling rejection of lower prices as buyers stepped back in. Price has broken above the 20-period SMA (Bollinger Band midline), reinforcing it as dynamic support, while declining volume near recent relative highs suggests limited selling pressure and a corrective pause. On the daily timeframe, LLY is consolidating within a bullish pennant that developed after an ascending channel, a textbook continuation pattern. A brief false bearish breakdown produced a strong daily pin bar with a long lower wick, indicating seller exhaustion and renewed demand. With daily volume remaining steady to rising, the technical structure favors a bullish trend continuation.

🎯 Suggested Trade Levels (for reference only)

  • Entry: $1075.05

  • Stop-Loss: $1064.45

  • Target: $1107.30

Levels are based on current technical structure and support/resistance zones. Manage risk accordingly.

Key Technical Signals

  • 4H Bullish Pin Bar Reversal with Confirmation: A classic bullish pin bar formed following a controlled pullback on the 4H chart, with the subsequent candle closing higher, confirming rejection of lower prices and validating the reversal signal.

  • 4H 20-Period SMA Reclaim (Middle Bollinger Band): Price closed back above the 20-period SMA on the 4H timeframe, reinforcing this level as dynamic trend support and signaling a shift back in favor of buyers.

  • 4H Volume Contraction at Relative Highs: Volume decreased near the most recent relative high, indicating a lack of aggressive selling pressure and supporting the view that the pullback was corrective rather than distributive.

  • Daily Bullish Pennant False Breakdown: On the daily timeframe, price briefly broke below the pennant structure but quickly reclaimed it, forming a false bearish breakout and trapping downside momentum.

  • Daily Pin Bar Rejection of Breakdown: The daily pin bar printed a long lower wick, signaling early selling pressure that was decisively rejected as buyers stepped in, reinforcing demand at lower levels.

  • Bullish Pennant Following Ascending Channel: The pennant formed after a well-defined ascending channel on the daily chart, aligning with a classic bullish continuation setup following an impulsive advance.

  • Constructive Daily Volume Profile: Daily volume has steadily increased without signs of capitulation or breakdown, supporting consolidation behavior and favoring an eventual volatility expansion in the direction of the prevailing trend.

4-Hour Chart Analysis (4H)

LLY | 4H Chart (TradingView)

On the 4H chart, LLY is consolidating within a broader uptrend, with price continuing to respect the 20-period moving average (the Bollinger Band midline) as dynamic support. After pulling back from the upper Bollinger Band, price found demand near the mid-band and printed a bullish pin bar, signaling rejection of lower prices. This signal was confirmed by the most recent bullish candle closing above the pin bar, strengthening the case that the pullback is corrective rather than a trend reversal. Price remains contained within the Bollinger Bands, with volatility contracting, which often precedes an expansion phase. Volume has remained relatively low during the consolidation, suggesting a lack of aggressive selling pressure and reinforcing the idea of healthy consolidation following the prior move. Resistance remains near the recent range highs around the upper band, while support is clearly defined near the mid-band and lower band. Overall, as long as LLY holds above the 20-period moving average, the technical structure favors bullish trend continuation once consolidation resolves.

Daily Chart Analysis (1D)

LLY | 1D Chart (TradingView)

On the daily chart, LLY remains in a primary uptrend, with price continuing to respect both the 9-day EMA (purple) and the 20-day SMA (Bollinger Band midline) as dynamic support. Following the sharp advance into late November, price entered a controlled pullback that found support near the lower Bollinger Band before reversing higher, re-establishing higher lows. Since mid-December, price has been trending higher within a clearly defined ascending channel, while recent candles show tight consolidation near the upper half of the range, suggesting strength rather than exhaustion. Note the narrowing price action outlined by the converging black trend lines is best characterized as a bullish pennant / flag-like consolidation, formed after an impulsive move higher, with price compressing between rising support and flat-to-slightly descending resistance. Volume has contracted during this consolidation, which is textbook behavior for a continuation pattern and indicates reduced selling pressure rather than distribution. As long as LLY continues to hold above the 9-day EMA and the 20-day SMA, the structure favors bullish continuation, with a decisive breakout above the pennant resistance opening the door for a measured move toward prior highs and the upper Bollinger Band, while a loss of the channel support would be the first signal of short-term trend weakness.

Sentiment Analysis Summary

Overall, the sentiment around Eli Lilly & Co. is predominantly bullish, driven by strong financial performance and positive future prospects. However, competition, particularly from Novo Nordisk, poses challenges that could temper growth expectations. While institutions show confidence with increased investments, careful consideration of market valuation and potential risks is necessary for future investments. Below are the key sentiment signals supporting this view:

  • Sterling Investment Counsel's significant increase in Eli Lilly's stock holdings reflects growing investor confidence in the company, supported by strong quarterly performance and favorable guidance.

  • Eli Lilly's strong financial results and elevated dividend are bolstering institutional investments, as seen with multiple firms increasing their stakes in the company.

  • Jim Cramer's endorsement of Eli Lilly suggests strong market enthusiasm and potential for stock growth driven by the anticipated GLP-1 pill.

  • Positive data from Eli Lilly's breast cancer treatment shows the company's diversified pharmaceutical strength beyond weight-loss drugs, potentially opening new revenue streams.

  • Institutional ownership of over 82% illustrates strong confidence in Eli Lilly among large investors, which typically suggests stability and growth potential for long-term share performance.

  • Eli Lilly is successfully navigating a competitive landscape in the obesity drug market, outperforming rivals and gaining market share, although potential challenges from competition remain.

Fundamental Analysis Summary

The overall outlook for Eli Lilly & Co appears bullish driven by substantial revenue and net income growth, improved liquidity, and better cash flow management. However, caution is advised due to rising debt levels and the associated financial risks, which require monitoring to ensure sustainable growth. The company is well-positioned for future expansions, especially in leveraging its strong equity base for investments and innovations. Below are the key fundamental signals supporting this view, based on TTM YoY fundamentals (Q3 2025 vs Q3 2024):

  • Total assets have increased significantly over the trailing twelve months, growing by 52.02%.

  • Revenues have exhibited consistent growth, up by 45.41%, indicating strong demand for products.

  • Net income has surged by 119.98%, reflecting effective cost management and increased sales.

  • Free cash flow has risen exceptionally by 562.37%, signaling strong operational efficiency.

  • Gross margin increased to 83.00%, highlighting improved profitability.

Brainlet Meme of the Day!

Remember: Protect your capital, the best loser wins.

Plugged into the market. Still no signal.

Liquidity provider spotted.

Thank you for being a Stocksift subscriber!

We hope you enjoyed this issue!

Best,
The Stocksift Team